Struggling chipmaker Advanced Micro Devices (AMD) lost ground in the fourth quarter to Intel in graphics chips and to Nvidia in graphics add-in boards, according to Jon Peddie Research. Intel (INTC) made big gains in graphics processing units in Q4. Its GPU market share rose to 71.4% from 66.8% in the year-earlier period, JPR said. No. 2 vendor Nvidia (NVDA) slipped a little in the GPU market last quarter. Its market share declined to 15% from
Graphics chipmaker Nvidia (NVDA) received an upgrade Monday based on the recent success of two new products and just ahead of its Q3 earnings due after the close Thursday. Strong demand for Nvidia’s recently launched high-end graphics processing cards, and expected delays in rival Advanced Micro Devices’ (AMD) competing products, “are likely to allow Nvidia to meet or exceed consensus estimates in the near and medium term,” Pacific Crest
Regeneron Pharmaceuticals (REGN) rebounded more than 6% in afternoon trading on the stock market today when development partner Sanofi (SNY) said in a U.S. regulatory filing that it will raise its stake from 20.44% to 22.5%. The French drug giant’s move comes after Regeneron superstar Eylea, a treatment for age-related macular degeneration (AMD), received a European Medicines Agency endorsement on Friday to expand its use to other types of vision